Public filings / EWTX on Yahoo Finance (opens in a new tab)
EWTX: insider buying, 13F holders, analyst moves
Edgewise Therapeutics Inc - US
A summary of public filings about Edgewise Therapeutics Inc - US. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
4 of our 100 managers hold EWTX
Combined reported value $671.4M.
Holders among our 100 managers: 4 in Q3 2023, 4 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| RA Capital | $341.0M | 2.96% | Trimmed |
| Perceptive Advisors | $177.7M | 2.76% | Trimmed |
| Baker Bros. Advisors | $150.4M | 0.75% | Trimmed |
| Tudor Investment | $2.3M | 0.01% | Added |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.